nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Rash generalised—Sunitinib—pancreatic cancer	0.0299	0.0357	CcSEcCtD
Carteolol—CYP2D6—Tamoxifen—pancreatic cancer	0.024	0.44	CbGbCtD
Carteolol—Keratitis—Erlotinib—pancreatic cancer	0.0227	0.027	CcSEcCtD
Carteolol—CYP2D6—Erlotinib—pancreatic cancer	0.0204	0.374	CbGbCtD
Carteolol—Lacrimation—Irinotecan—pancreatic cancer	0.0178	0.0212	CcSEcCtD
Carteolol—Lacrimation—Fluorouracil—pancreatic cancer	0.0171	0.0203	CcSEcCtD
Carteolol—Rash generalised—Docetaxel—pancreatic cancer	0.017	0.0203	CcSEcCtD
Carteolol—Lacrimation increased—Sunitinib—pancreatic cancer	0.0138	0.0164	CcSEcCtD
Carteolol—Respiratory failure—Sunitinib—pancreatic cancer	0.013	0.0154	CcSEcCtD
Carteolol—Lacrimation—Docetaxel—pancreatic cancer	0.0123	0.0147	CcSEcCtD
Carteolol—Eye irritation—Fluorouracil—pancreatic cancer	0.0118	0.014	CcSEcCtD
Carteolol—Visual disturbance—Tamoxifen—pancreatic cancer	0.0114	0.0136	CcSEcCtD
Carteolol—Lacrimation increased—Irinotecan—pancreatic cancer	0.0114	0.0135	CcSEcCtD
Carteolol—Lacrimation increased—Fluorouracil—pancreatic cancer	0.0109	0.013	CcSEcCtD
Carteolol—Cerebrovascular accident—Erlotinib—pancreatic cancer	0.0109	0.013	CcSEcCtD
Carteolol—Respiratory failure—Gemcitabine—pancreatic cancer	0.0104	0.0124	CcSEcCtD
Carteolol—Cardiac failure congestive—Sunitinib—pancreatic cancer	0.0102	0.0121	CcSEcCtD
Carteolol—CYP2D6—Doxorubicin—pancreatic cancer	0.0101	0.185	CbGbCtD
Carteolol—Hypoglycaemia—Sunitinib—pancreatic cancer	0.00946	0.0113	CcSEcCtD
Carteolol—Cerebrovascular accident—Sunitinib—pancreatic cancer	0.00942	0.0112	CcSEcCtD
Carteolol—Photophobia—Fluorouracil—pancreatic cancer	0.00942	0.0112	CcSEcCtD
Carteolol—Eye irritation—Docetaxel—pancreatic cancer	0.00848	0.0101	CcSEcCtD
Carteolol—Lacrimation—Epirubicin—pancreatic cancer	0.00831	0.0099	CcSEcCtD
Carteolol—Depression—Tamoxifen—pancreatic cancer	0.00828	0.00987	CcSEcCtD
Carteolol—Depression—Erlotinib—pancreatic cancer	0.00819	0.00977	CcSEcCtD
Carteolol—Cardiac failure congestive—Gemcitabine—pancreatic cancer	0.00817	0.00973	CcSEcCtD
Carteolol—Visual disturbance—Irinotecan—pancreatic cancer	0.00802	0.00956	CcSEcCtD
Carteolol—Conjunctivitis—Erlotinib—pancreatic cancer	0.00799	0.00952	CcSEcCtD
Carteolol—Lacrimation increased—Docetaxel—pancreatic cancer	0.00786	0.00937	CcSEcCtD
Carteolol—Sinusitis—Tamoxifen—pancreatic cancer	0.00779	0.00929	CcSEcCtD
Carteolol—Cerebrovascular accident—Irinotecan—pancreatic cancer	0.00776	0.00925	CcSEcCtD
Carteolol—Lacrimation—Doxorubicin—pancreatic cancer	0.00769	0.00916	CcSEcCtD
Carteolol—Cerebrovascular accident—Gemcitabine—pancreatic cancer	0.00756	0.00901	CcSEcCtD
Carteolol—Keratitis—Epirubicin—pancreatic cancer	0.00753	0.00898	CcSEcCtD
Carteolol—Respiratory failure—Docetaxel—pancreatic cancer	0.00737	0.00879	CcSEcCtD
Carteolol—Visual impairment—Tamoxifen—pancreatic cancer	0.00719	0.00856	CcSEcCtD
Carteolol—Depression—Sunitinib—pancreatic cancer	0.00709	0.00845	CcSEcCtD
Carteolol—Keratitis—Doxorubicin—pancreatic cancer	0.00697	0.0083	CcSEcCtD
Carteolol—Arrhythmia—Tamoxifen—pancreatic cancer	0.00666	0.00794	CcSEcCtD
Carteolol—Arrhythmia—Erlotinib—pancreatic cancer	0.00659	0.00785	CcSEcCtD
Carteolol—Bradycardia—Sunitinib—pancreatic cancer	0.0065	0.00775	CcSEcCtD
Carteolol—Dysgeusia—Tamoxifen—pancreatic cancer	0.00636	0.00758	CcSEcCtD
Carteolol—Bronchospasm—Gemcitabine—pancreatic cancer	0.0063	0.00751	CcSEcCtD
Carteolol—Cardiac failure congestive—Docetaxel—pancreatic cancer	0.0058	0.00691	CcSEcCtD
Carteolol—Syncope—Erlotinib—pancreatic cancer	0.00576	0.00686	CcSEcCtD
Carteolol—Arrhythmia—Sunitinib—pancreatic cancer	0.00571	0.0068	CcSEcCtD
Carteolol—Loss of consciousness—Erlotinib—pancreatic cancer	0.00564	0.00673	CcSEcCtD
Carteolol—Visual disturbance—Docetaxel—pancreatic cancer	0.00555	0.00661	CcSEcCtD
Carteolol—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00546	0.0065	CcSEcCtD
Carteolol—Dysgeusia—Sunitinib—pancreatic cancer	0.00544	0.00649	CcSEcCtD
Carteolol—Bradycardia—Irinotecan—pancreatic cancer	0.00536	0.00638	CcSEcCtD
Carteolol—Lacrimation increased—Epirubicin—pancreatic cancer	0.0053	0.00632	CcSEcCtD
Carteolol—Oedema—Tamoxifen—pancreatic cancer	0.0053	0.00631	CcSEcCtD
Carteolol—Sinusitis—Fluorouracil—pancreatic cancer	0.00527	0.00628	CcSEcCtD
Carteolol—Oedema—Erlotinib—pancreatic cancer	0.00524	0.00625	CcSEcCtD
Carteolol—Shock—Erlotinib—pancreatic cancer	0.00516	0.00615	CcSEcCtD
Carteolol—Visual impairment—Irinotecan—pancreatic cancer	0.00507	0.00604	CcSEcCtD
Carteolol—Atrioventricular block—Epirubicin—pancreatic cancer	0.00504	0.006	CcSEcCtD
Carteolol—Lacrimation increased—Doxorubicin—pancreatic cancer	0.0049	0.00584	CcSEcCtD
Carteolol—Insomnia—Tamoxifen—pancreatic cancer	0.00479	0.00571	CcSEcCtD
Carteolol—Insomnia—Erlotinib—pancreatic cancer	0.00474	0.00565	CcSEcCtD
Carteolol—Dyspnoea—Tamoxifen—pancreatic cancer	0.00472	0.00563	CcSEcCtD
Carteolol—Arrhythmia—Irinotecan—pancreatic cancer	0.0047	0.0056	CcSEcCtD
Carteolol—Dyspnoea—Erlotinib—pancreatic cancer	0.00467	0.00557	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00466	0.00555	CcSEcCtD
Carteolol—Arrhythmia—Gemcitabine—pancreatic cancer	0.00458	0.00546	CcSEcCtD
Carteolol—Oedema—Sunitinib—pancreatic cancer	0.00454	0.00541	CcSEcCtD
Carteolol—Arrhythmia—Fluorouracil—pancreatic cancer	0.0045	0.00536	CcSEcCtD
Carteolol—Bronchospasm—Docetaxel—pancreatic cancer	0.00447	0.00533	CcSEcCtD
Carteolol—Shock—Sunitinib—pancreatic cancer	0.00446	0.00532	CcSEcCtD
Carteolol—Vision blurred—Fluorouracil—pancreatic cancer	0.00413	0.00493	CcSEcCtD
Carteolol—Syncope—Irinotecan—pancreatic cancer	0.00411	0.00489	CcSEcCtD
Carteolol—Insomnia—Sunitinib—pancreatic cancer	0.0041	0.00489	CcSEcCtD
Carteolol—Diabetes mellitus—Epirubicin—pancreatic cancer	0.00408	0.00486	CcSEcCtD
Carteolol—Dyspnoea—Sunitinib—pancreatic cancer	0.00405	0.00482	CcSEcCtD
Carteolol—Loss of consciousness—Irinotecan—pancreatic cancer	0.00403	0.0048	CcSEcCtD
Carteolol—Conjunctivitis—Docetaxel—pancreatic cancer	0.00394	0.00469	CcSEcCtD
Carteolol—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.00391	0.00466	CcSEcCtD
Carteolol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.0039	0.00465	CcSEcCtD
Carteolol—Asthenia—Tamoxifen—pancreatic cancer	0.0038	0.00453	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.00377	0.0045	CcSEcCtD
Carteolol—Asthenia—Erlotinib—pancreatic cancer	0.00376	0.00448	CcSEcCtD
Carteolol—Oedema—Irinotecan—pancreatic cancer	0.00374	0.00445	CcSEcCtD
Carteolol—Shock—Irinotecan—pancreatic cancer	0.00368	0.00438	CcSEcCtD
Carteolol—Oedema—Gemcitabine—pancreatic cancer	0.00364	0.00434	CcSEcCtD
Carteolol—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00363	0.00433	CcSEcCtD
Carteolol—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.00362	0.00431	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.00362	0.00431	CcSEcCtD
Carteolol—Oedema—Fluorouracil—pancreatic cancer	0.00358	0.00427	CcSEcCtD
Carteolol—Diplopia—Epirubicin—pancreatic cancer	0.00355	0.00423	CcSEcCtD
Carteolol—Visual impairment—Docetaxel—pancreatic cancer	0.0035	0.00418	CcSEcCtD
Carteolol—Dizziness—Tamoxifen—pancreatic cancer	0.0035	0.00418	CcSEcCtD
Carteolol—Hypotension—Irinotecan—pancreatic cancer	0.00349	0.00416	CcSEcCtD
Carteolol—Dizziness—Erlotinib—pancreatic cancer	0.00347	0.00413	CcSEcCtD
Carteolol—Hypotension—Gemcitabine—pancreatic cancer	0.0034	0.00405	CcSEcCtD
Carteolol—Insomnia—Irinotecan—pancreatic cancer	0.00338	0.00403	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00336	0.00401	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.00335	0.00399	CcSEcCtD
Carteolol—Hypotension—Fluorouracil—pancreatic cancer	0.00334	0.00399	CcSEcCtD
Carteolol—Hypersensitivity—Sunitinib—pancreatic cancer	0.00334	0.00398	CcSEcCtD
Carteolol—Dyspnoea—Irinotecan—pancreatic cancer	0.00333	0.00397	CcSEcCtD
Carteolol—Headache—Tamoxifen—pancreatic cancer	0.00332	0.00396	CcSEcCtD
Carteolol—Insomnia—Gemcitabine—pancreatic cancer	0.00329	0.00392	CcSEcCtD
Carteolol—Headache—Erlotinib—pancreatic cancer	0.00328	0.00391	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—pancreatic cancer	0.00328	0.00391	CcSEcCtD
Carteolol—Asthenia—Sunitinib—pancreatic cancer	0.00326	0.00388	CcSEcCtD
Carteolol—Arrhythmia—Docetaxel—pancreatic cancer	0.00325	0.00387	CcSEcCtD
Carteolol—Dyspnoea—Gemcitabine—pancreatic cancer	0.00325	0.00387	CcSEcCtD
Carteolol—Insomnia—Fluorouracil—pancreatic cancer	0.00324	0.00386	CcSEcCtD
Carteolol—Dyspnoea—Fluorouracil—pancreatic cancer	0.00319	0.0038	CcSEcCtD
Carteolol—Nausea—Tamoxifen—pancreatic cancer	0.00315	0.00375	CcSEcCtD
Carteolol—Nausea—Erlotinib—pancreatic cancer	0.00311	0.00371	CcSEcCtD
Carteolol—Dysgeusia—Docetaxel—pancreatic cancer	0.0031	0.00369	CcSEcCtD
Carteolol—Dizziness—Sunitinib—pancreatic cancer	0.003	0.00358	CcSEcCtD
Carteolol—Headache—Sunitinib—pancreatic cancer	0.00284	0.00339	CcSEcCtD
Carteolol—Syncope—Docetaxel—pancreatic cancer	0.00284	0.00338	CcSEcCtD
Carteolol—Palpitations—Docetaxel—pancreatic cancer	0.0028	0.00333	CcSEcCtD
Carteolol—Loss of consciousness—Docetaxel—pancreatic cancer	0.00278	0.00332	CcSEcCtD
Carteolol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00275	0.00328	CcSEcCtD
Carteolol—Nausea—Sunitinib—pancreatic cancer	0.0027	0.00321	CcSEcCtD
Carteolol—Asthenia—Irinotecan—pancreatic cancer	0.00268	0.0032	CcSEcCtD
Carteolol—Conjunctivitis—Epirubicin—pancreatic cancer	0.00266	0.00317	CcSEcCtD
Carteolol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00264	0.00314	CcSEcCtD
Carteolol—Asthenia—Gemcitabine—pancreatic cancer	0.00261	0.00311	CcSEcCtD
Carteolol—Oedema—Docetaxel—pancreatic cancer	0.00258	0.00308	CcSEcCtD
Carteolol—Sinusitis—Epirubicin—pancreatic cancer	0.00256	0.00306	CcSEcCtD
Carteolol—Shock—Docetaxel—pancreatic cancer	0.00254	0.00303	CcSEcCtD
Carteolol—Bradycardia—Epirubicin—pancreatic cancer	0.0025	0.00298	CcSEcCtD
Carteolol—Dizziness—Irinotecan—pancreatic cancer	0.00247	0.00295	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00246	0.00293	CcSEcCtD
Carteolol—Hypotension—Docetaxel—pancreatic cancer	0.00241	0.00288	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—pancreatic cancer	0.00237	0.00283	CcSEcCtD
Carteolol—Dizziness—Fluorouracil—pancreatic cancer	0.00237	0.00282	CcSEcCtD
Carteolol—Visual impairment—Epirubicin—pancreatic cancer	0.00236	0.00282	CcSEcCtD
Carteolol—Headache—Irinotecan—pancreatic cancer	0.00234	0.00279	CcSEcCtD
Carteolol—Insomnia—Docetaxel—pancreatic cancer	0.00234	0.00279	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—pancreatic cancer	0.00231	0.00275	CcSEcCtD
Carteolol—Dyspnoea—Docetaxel—pancreatic cancer	0.0023	0.00275	CcSEcCtD
Carteolol—Headache—Gemcitabine—pancreatic cancer	0.00228	0.00272	CcSEcCtD
Carteolol—Headache—Fluorouracil—pancreatic cancer	0.00224	0.00267	CcSEcCtD
Carteolol—Nausea—Irinotecan—pancreatic cancer	0.00222	0.00265	CcSEcCtD
Carteolol—Arrhythmia—Epirubicin—pancreatic cancer	0.00219	0.00261	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—pancreatic cancer	0.00219	0.00261	CcSEcCtD
Carteolol—Nausea—Gemcitabine—pancreatic cancer	0.00216	0.00258	CcSEcCtD
Carteolol—Nausea—Fluorouracil—pancreatic cancer	0.00213	0.00253	CcSEcCtD
Carteolol—Dysgeusia—Epirubicin—pancreatic cancer	0.00209	0.00249	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—pancreatic cancer	0.00203	0.00242	CcSEcCtD
Carteolol—Vision blurred—Epirubicin—pancreatic cancer	0.00201	0.0024	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—pancreatic cancer	0.00193	0.00231	CcSEcCtD
Carteolol—Syncope—Epirubicin—pancreatic cancer	0.00191	0.00228	CcSEcCtD
Carteolol—Hypersensitivity—Docetaxel—pancreatic cancer	0.0019	0.00227	CcSEcCtD
Carteolol—Palpitations—Epirubicin—pancreatic cancer	0.00189	0.00225	CcSEcCtD
Carteolol—Loss of consciousness—Epirubicin—pancreatic cancer	0.00188	0.00224	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—pancreatic cancer	0.00186	0.00222	CcSEcCtD
Carteolol—Asthenia—Docetaxel—pancreatic cancer	0.00185	0.00221	CcSEcCtD
Carteolol—Syncope—Doxorubicin—pancreatic cancer	0.00177	0.00211	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—pancreatic cancer	0.00175	0.00208	CcSEcCtD
Carteolol—Oedema—Epirubicin—pancreatic cancer	0.00174	0.00208	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00174	0.00207	CcSEcCtD
Carteolol—Shock—Epirubicin—pancreatic cancer	0.00171	0.00204	CcSEcCtD
Carteolol—Dizziness—Docetaxel—pancreatic cancer	0.00171	0.00204	CcSEcCtD
Carteolol—Hypotension—Epirubicin—pancreatic cancer	0.00163	0.00194	CcSEcCtD
Carteolol—Headache—Docetaxel—pancreatic cancer	0.00162	0.00193	CcSEcCtD
Carteolol—Oedema—Doxorubicin—pancreatic cancer	0.00161	0.00192	CcSEcCtD
Carteolol—Shock—Doxorubicin—pancreatic cancer	0.00159	0.00189	CcSEcCtD
Carteolol—Insomnia—Epirubicin—pancreatic cancer	0.00158	0.00188	CcSEcCtD
Carteolol—Dyspnoea—Epirubicin—pancreatic cancer	0.00155	0.00185	CcSEcCtD
Carteolol—Nausea—Docetaxel—pancreatic cancer	0.00153	0.00183	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—pancreatic cancer	0.00151	0.0018	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—pancreatic cancer	0.00146	0.00174	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—pancreatic cancer	0.00144	0.00171	CcSEcCtD
Carteolol—Hypersensitivity—Epirubicin—pancreatic cancer	0.00128	0.00153	CcSEcCtD
Carteolol—Asthenia—Epirubicin—pancreatic cancer	0.00125	0.00149	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00119	0.00142	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—pancreatic cancer	0.00116	0.00138	CcSEcCtD
Carteolol—Dizziness—Epirubicin—pancreatic cancer	0.00115	0.00137	CcSEcCtD
Carteolol—Headache—Epirubicin—pancreatic cancer	0.00109	0.0013	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—pancreatic cancer	0.00107	0.00127	CcSEcCtD
Carteolol—Nausea—Epirubicin—pancreatic cancer	0.00104	0.00123	CcSEcCtD
Carteolol—Headache—Doxorubicin—pancreatic cancer	0.00101	0.0012	CcSEcCtD
Carteolol—Nausea—Doxorubicin—pancreatic cancer	0.000958	0.00114	CcSEcCtD
Carteolol—ADRB2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000297	0.0028	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CNR1—pancreatic cancer	0.000293	0.00275	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000293	0.00275	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PPY—pancreatic cancer	0.000292	0.00274	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—GCG—pancreatic cancer	0.000289	0.00272	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000286	0.00269	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—GCG—pancreatic cancer	0.000283	0.00266	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000283	0.00266	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000277	0.0026	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000276	0.00259	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—AGTR1—pancreatic cancer	0.00027	0.00254	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GAST—pancreatic cancer	0.000268	0.00252	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GAST—pancreatic cancer	0.000262	0.00246	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—SCT—pancreatic cancer	0.000254	0.00239	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—SCT—pancreatic cancer	0.000248	0.00233	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GAST—pancreatic cancer	0.000243	0.00228	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CCK—pancreatic cancer	0.000242	0.00228	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GAST—pancreatic cancer	0.000238	0.00223	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CCK—pancreatic cancer	0.000237	0.00223	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000236	0.00222	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000236	0.00222	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000232	0.00218	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000231	0.00217	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000231	0.00217	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—SCT—pancreatic cancer	0.00023	0.00217	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000227	0.00213	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	0.000225	0.00212	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRLHR—pancreatic cancer	0.00022	0.00207	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCK—pancreatic cancer	0.00022	0.00207	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	0.000216	0.00203	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	0.000215	0.00202	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CNR2—pancreatic cancer	0.000214	0.00201	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000214	0.00201	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000211	0.00198	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	0.00021	0.00197	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	0.00021	0.00197	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000209	0.00196	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000207	0.00195	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000207	0.00195	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000206	0.00194	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000204	0.00192	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000203	0.0019	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000203	0.0019	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000201	0.00189	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000196	0.00184	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—SHH—pancreatic cancer	0.000192	0.00181	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IAPP—pancreatic cancer	0.00019	0.00178	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	0.000188	0.00177	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SSTR3—pancreatic cancer	0.000187	0.00176	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DTX1—pancreatic cancer	0.000187	0.00176	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	0.000186	0.00174	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—SST—pancreatic cancer	0.000183	0.00172	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	0.000183	0.00172	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	0.000183	0.00172	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000182	0.00171	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000182	0.00171	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	0.00018	0.00169	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	0.000179	0.00169	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000178	0.00167	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000178	0.00167	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	0.000176	0.00166	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000176	0.00165	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	0.000173	0.00163	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	0.000172	0.00162	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000169	0.00159	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.000169	0.00159	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	0.000167	0.00157	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	0.000167	0.00157	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000166	0.00156	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000166	0.00156	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	0.000164	0.00154	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.000163	0.00154	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	0.000163	0.00153	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000162	0.00153	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	0.00016	0.0015	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	0.000157	0.00148	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	0.000157	0.00148	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000156	0.00147	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	0.000154	0.00145	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.000154	0.00144	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.000154	0.00144	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000153	0.00144	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000153	0.00144	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000153	0.00143	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.00015	0.00141	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000149	0.0014	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000149	0.0014	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.000148	0.0014	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.000147	0.00138	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000145	0.00137	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.000144	0.00135	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.000144	0.00135	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000142	0.00133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.00014	0.00132	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000139	0.0013	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.000136	0.00128	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.000136	0.00128	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000133	0.00125	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000133	0.00125	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.00013	0.00122	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000127	0.00119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000127	0.00119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000127	0.00119	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000126	0.00119	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.000124	0.00117	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000124	0.00116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000124	0.00116	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000124	0.00116	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000122	0.00114	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	0.000121	0.00114	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.000121	0.00113	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.000119	0.00112	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000118	0.00111	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.000116	0.00109	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.000114	0.00107	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000113	0.00106	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000112	0.00105	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.000111	0.00104	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.00011	0.00104	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.00011	0.00103	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	0.000108	0.00101	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	0.000108	0.00101	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.000105	0.000989	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.000105	0.000989	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ARG2—pancreatic cancer	0.000105	0.000989	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	9.84e-05	0.000925	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	9.71e-05	0.000912	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	9.63e-05	0.000905	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	9.63e-05	0.000905	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	9.59e-05	0.000901	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	9.49e-05	0.000892	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	9.42e-05	0.000886	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	9.38e-05	0.000882	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TYMP—pancreatic cancer	9.2e-05	0.000865	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	9.08e-05	0.000854	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	8.88e-05	0.000835	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	8.81e-05	0.000828	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	8.77e-05	0.000824	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	8.62e-05	0.00081	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	8.58e-05	0.000807	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.53e-05	0.000802	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	8.37e-05	0.000787	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.35e-05	0.000785	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	8.25e-05	0.000775	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	8.19e-05	0.000769	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	8.07e-05	0.000758	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	7.75e-05	0.000728	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	7.58e-05	0.000712	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.44e-05	0.000699	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	7.41e-05	0.000697	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DPYD—pancreatic cancer	7.29e-05	0.000686	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.28e-05	0.000684	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	7.22e-05	0.000679	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.15e-05	0.000672	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	7.07e-05	0.000664	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	7.05e-05	0.000663	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	6.99e-05	0.000657	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	6.92e-05	0.000651	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	6.9e-05	0.000648	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.75e-05	0.000635	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	6.61e-05	0.000621	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	6.49e-05	0.00061	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	6.35e-05	0.000597	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	6.18e-05	0.000581	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	6.05e-05	0.000568	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	5.91e-05	0.000556	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	5.9e-05	0.000554	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	5.78e-05	0.000543	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	5.77e-05	0.000542	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	5.77e-05	0.000542	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	5.65e-05	0.000531	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	5.64e-05	0.00053	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	5.53e-05	0.00052	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	5.38e-05	0.000505	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD44—pancreatic cancer	5.36e-05	0.000504	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	5.32e-05	0.0005	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	5.26e-05	0.000494	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	5.21e-05	0.00049	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	5.21e-05	0.000489	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	5.21e-05	0.000489	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	5.15e-05	0.000484	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCG—pancreatic cancer	5.14e-05	0.000483	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	5.09e-05	0.000479	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	5.09e-05	0.000479	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	5.03e-05	0.000473	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—STK11—pancreatic cancer	4.83e-05	0.000454	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	4.74e-05	0.000446	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	4.64e-05	0.000436	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	4.58e-05	0.00043	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.53e-05	0.000426	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	4.48e-05	0.000421	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	4.48e-05	0.000421	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.44e-05	0.000417	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	4.38e-05	0.000412	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.16e-05	0.000391	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.12e-05	0.000387	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.03e-05	0.000379	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	3.99e-05	0.000375	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	3.9e-05	0.000367	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	3.83e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	3.81e-05	0.000358	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	3.75e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	3.73e-05	0.00035	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	3.7e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	3.67e-05	0.000345	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	3.62e-05	0.000341	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	3.59e-05	0.000337	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	3.57e-05	0.000336	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	3.54e-05	0.000332	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	3.49e-05	0.000328	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	3.47e-05	0.000326	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	3.46e-05	0.000325	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	3.45e-05	0.000324	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	3.39e-05	0.000319	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—pancreatic cancer	3.38e-05	0.000318	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	3.37e-05	0.000317	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	3.36e-05	0.000316	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	3.29e-05	0.000309	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	3.2e-05	0.000301	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	3.13e-05	0.000294	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	3.11e-05	0.000293	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	3.08e-05	0.00029	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	3.08e-05	0.000289	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.05e-05	0.000287	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	3.05e-05	0.000286	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	3.02e-05	0.000284	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	3.01e-05	0.000283	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.94e-05	0.000277	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	2.87e-05	0.000269	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	2.86e-05	0.000269	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	2.8e-05	0.000263	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	2.8e-05	0.000263	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	2.8e-05	0.000263	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	2.74e-05	0.000258	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.68e-05	0.000252	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	2.65e-05	0.000249	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	2.59e-05	0.000243	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	2.43e-05	0.000229	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	2.38e-05	0.000224	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	2.35e-05	0.000221	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.34e-05	0.00022	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.32e-05	0.000218	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	2.3e-05	0.000216	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.25e-05	0.000212	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.2e-05	0.000207	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.02e-05	0.00019	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	1.99e-05	0.000187	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	1.94e-05	0.000183	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.42e-05	0.000134	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.16e-05	0.000109	CbGpPWpGaD
